BioLineRx Ltd. (BLRX)
2.83
-0.05
(-1.74%)
USD |
NASDAQ |
Feb 27, 16:00
2.86
+0.03
(+1.06%)
After-Hours: 20:00
BioLineRx EPS Diluted (Quarterly) : -0.223 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Compugen Ltd. | -0.0746 |
| Pluri, Inc. | -0.7066 |
| XTL Biopharmaceuticals Ltd. | -0.0292 |
| Can-Fite BioPharma Ltd. | -- |
| Evogene Ltd. | 0.4444 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.9816M |
| Revenue (Quarterly) | 0.429M |
| Total Expenses (Quarterly) | 1.411M |
| Enterprise Value | -1.520M |
| Gross Profit Margin (Quarterly) | 52.45% |
| Profit Margin (Quarterly) | -228.8% |
| Earnings Yield | -48.51% |
| Normalized Earnings Yield | -36.80 |